| Human occludin is a hepatitis C virus entry factor required for infection of mouse cells A Ploss, MJ Evans, VA Gaysinskaya, M Panis, H You, YP De Jong, ... Nature 457 (7231), 882-886, 2009 | 1212 | 2009 |
| HIV therapy by a combination of broadly neutralizing antibodies in humanized mice F Klein, A Halper-Stromberg, JA Horwitz, H Gruell, JF Scheid, ... Nature 492 (7427), 118-122, 2012 | 581 | 2012 |
| Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro BD Lindenbach, P Meuleman, A Ploss, T Vanwolleghem, AJ Syder, ... Proceedings of the National Academy of Sciences 103 (10), 3805-3809, 2006 | 567 | 2006 |
| Decoding type I and III interferon signalling during viral infection EV Mesev, RA LeDesma, A Ploss Nature microbiology 4 (6), 914-924, 2019 | 452 | 2019 |
| A genetically humanized mouse model for hepatitis C virus infection M Dorner, JA Horwitz, JB Robbins, WT Barry, Q Feng, K Mu, CT Jones, ... Nature 474 (7350), 208-211, 2011 | 446 | 2011 |
| The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response RS Akondy, ND Monson, JD Miller, S Edupuganti, D Teuwen, H Wu, ... The Journal of Immunology 183 (12), 7919-7930, 2009 | 369 | 2009 |
| Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus E Giang, M Dorner, JC Prentoe, M Dreux, MJ Evans, J Bukh, CM Rice, ... Proceedings of the National Academy of Sciences 109 (16), 6205-6210, 2012 | 363 | 2012 |
| A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease ML Washburn, MT Bility, L Zhang, GI Kovalev, A Buntzman, JA Frelinger, ... Gastroenterology 140 (4), 1334-1344, 2011 | 363 | 2011 |
| AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges MR Gardner, LM Kattenhorn, HR Kondur, M Von Schaewen, T Dorfman, ... Nature 519 (7541), 87-91, 2015 | 338 | 2015 |
| Priming of protective T cell responses against virus-induced tumors in mice with human immune system components T Strowig, C Gurer, A Ploss, YF Liu, F Arrey, J Sashihara, G Koo, CM Rice, ... Journal of Experimental Medicine 206 (6), 1423-1434, 2009 | 330 | 2009 |
| Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor–, granulocyte-macrophage colony-stimulating factor–, and interleukin-3–expressing NOD … E Billerbeck, WT Barry, K Mu, M Dorner, CM Rice, A Ploss Blood, The Journal of the American Society of Hematology 117 (11), 3076-3086, 2011 | 318 | 2011 |
| Hepatitis E virus: advances and challenges I Nimgaonkar, Q Ding, RE Schwartz, A Ploss Nature Reviews Gastroenterology & Hepatology 15 (2), 96-110, 2018 | 313 | 2018 |
| HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice JA Horwitz, A Halper-Stromberg, H Mouquet, AD Gitlin, A Tretiakova, ... Proceedings of the National Academy of Sciences 110 (41), 16538-16543, 2013 | 295 | 2013 |
| Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system CT Jones, MT Catanese, LMJ Law, SR Khetani, AJ Syder, A Ploss, TS Oh, ... Nature biotechnology 28 (2), 167-171, 2010 | 283 | 2010 |
| Humanized mice for modeling human infectious disease: challenges, progress, and outlook N Legrand, A Ploss, R Balling, PD Becker, C Borsotti, N Brezillon, ... Cell host & microbe 6 (1), 5-9, 2009 | 267 | 2009 |
| Completion of the entire hepatitis C virus life cycle in genetically humanized mice M Dorner, JA Horwitz, BM Donovan, RN Labitt, WC Budell, T Friling, ... Nature 501 (7466), 237-241, 2013 | 260 | 2013 |
| Modeling hepatitis C virus infection using human induced pluripotent stem cells RE Schwartz, K Trehan, L Andrus, TP Sheahan, A Ploss, SA Duncan, ... Proceedings of the National Academy of Sciences 109 (7), 2544-2548, 2012 | 258 | 2012 |
| Complete Plasmodium falciparum liver-stage development in liver-chimeric mice AM Vaughan, SA Mikolajczak, EM Wilson, M Grompe, A Kaushansky, ... The Journal of clinical investigation 122 (10), 3618-3628, 2012 | 243 | 2012 |
| Broadly neutralizing antibodies abrogate established hepatitis C virus infection YP De Jong, M Dorner, MC Mommersteeg, JW Xiao, AB Balazs, ... Science translational medicine 6 (254), 254ra129-254ra129, 2014 | 239 | 2014 |
| Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures A Ploss, SR Khetani, CT Jones, AJ Syder, K Trehan, VA Gaysinskaya, ... Proceedings of the National Academy of Sciences 107 (7), 3141-3145, 2010 | 238 | 2010 |
